Diagnostic Yield and Variant Spectrum in 375 Patients with Segmental Overgrowth and Vascular Malformations: Implications for Panel Design and Molecular Testing Strategies
Segmental overgrowth and vascular malformations comprise a group of diseases caused by postzygotic variants in genes that regulate cell growth, proliferation, and angiogenesis. The best-characterized group is the PIK3CA-related overgrowth spectrum (PROS), which includes syndromes sharing variants in the PIK3CA gene. Beyond PIK3CA, the genes involved fall into two mechanistically distinct groups, with gain-of-function (GNAQ, GNA11, TEK, AKT1, AKT3, MTOR, PIK3R1) and loss-of-function (RASA1, GLMN, PTEN) causative variants. What remains poorly established is how effectively a molecular diagnosis is actually achieved in routine practice, and how this depends on the referral clinical diagnosis. By targeted panel deep sequencing in patients with segmental overgrowth and/or a vascular malformation, we have identified at least one pathogenic / likely pathogenic (P/LP) genetic variant in 266 of the 375 successfully tested patients, giving an overall diagnostic yield of 70.9%. The yield was 63.5% in patients with isolated overgrowth (94 of 148), 75.0% in patients with an isolated vascular malformation (111 of 148) and 77.2% in patients with a combined or syndromic phenotype (61 of 79). The 277 P/LP variants identified were distributed across 17 genes; PIK3CA accounted for 141 variants (50.9%), GNAQ for 44 (15.9%), TEK for 31 (11.2%), RASA1 for 15 (5.4%) and GNA11 for 11 (4.0%); these five genes together accounted for 87.4% of the variants. The spectrum was highly concentrated: the ten most frequent variants accounted for 57.0% of the P/LP variants, with GNAQ variant p.Arg183Gln (15.2%) and PIK3CA hotspot variants p.Glu542Lys (8.7%), p.Glu545Lys (6.9%), and p.His1047Arg (7.6%). In several genes, variants were restricted to specific regions: in GNAQ and GNA11 to two codons, 183 and 209 (98.2% of all findings), and in TEK to the 3′-terminus. Considered together with the referral diagnosis, the distribution of variants, their allele fractions and their mechanisms of pathogenicity suggest molecular testing strategies.
Authors
- Daria Guseva (ORCID: https://orcid.org/0000-0003-3761-8595)
- G. B. Sagoyan (ORCID: https://orcid.org/0000-0002-7846-3473)
- Руслан Асланчериевич Хагуров (ORCID: https://orcid.org/0000-0001-7944-8438)
- V. V. Strelnikov (ORCID: https://orcid.org/0000-0001-9283-902X)
- Ilya V. Volodin (ORCID: https://orcid.org/0000-0001-6539-3763)
- Sergey Ivanovich Kutsev (ORCID: https://orcid.org/0000-0002-3133-8018)
- Natalia A. Semenova (ORCID: https://orcid.org/0000-0001-7041-045X)
- E. Yu. Bychkova (ORCID: https://orcid.org/0000-0002-4467-1151)
- Grigory A. Somsikov
- Seyfulla V. Alimov
- Alexander E. Zhigulin
Institutions
- Russian Cancer Research Center NN Blokhin (RU)
- St. Vladimir Children's Moscow Clinical Hospital (RU)
- Ministry of Health of the Russian Federation (RU)
- Research Centre for Medical Genetics (RU)
- City Clinical Hospital No15 named. O. M. Filatova (RU)
Publication Details
- Journal
- International Journal of Molecular Sciences
- Published
- 2026-11-12
- DOI
- https://doi.org/10.3390/ijms272210127
- Primary Topic
- Vascular Malformations and Hemangiomas
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Ministry of Science and Higher Education of the Russian Federation